Interim Report
January 1 – March, 2016The first quarter in figures · Total net sales amounted to TSEK 1,066 (1,057). · The loss after tax amounted to TSEK 11,600 (9,179). · The loss per share amounted to SEK 1.40 (1.84). · The cash flow from current operations was negative in the amount of TSEK 11,247 (9,197). · Significant margin improvement with gross margin increasing to 26.3% in Q1 (2.6% Q1 15). Important events during the quarter · SciBase’s PMA application was accepted on January 14th as complete starting the formal evaluation process by the FDA. There has been a high level